426 related articles for article (PubMed ID: 29961581)
1. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
[TBL] [Abstract][Full Text] [Related]
2. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
[TBL] [Abstract][Full Text] [Related]
3. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
Joint Head and Neck Radiotherapy-MRI Development Cooperative
Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
[TBL] [Abstract][Full Text] [Related]
4. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
[TBL] [Abstract][Full Text] [Related]
5. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
[TBL] [Abstract][Full Text] [Related]
6. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
7. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
8. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
[TBL] [Abstract][Full Text] [Related]
9. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.
Barbon CEA; Peterson CB; Moreno AC; Lai SY; Reddy JP; Sahli A; Martino R; Johnson FM; Fuller CD; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):956-964. PubMed ID: 36074459
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
[TBL] [Abstract][Full Text] [Related]
11. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma.
Gharzai LA; Li P; Schipper MJ; Yao J; Mayo CS; Wilkie JR; Hawkins PG; Lyden T; Blakely A; Ibrahim M; Schonewolf CA; Shah J; Eisbruch A; Casper K; Mierzwa M
Oral Oncol; 2020 Dec; 111():104853. PubMed ID: 32805634
[TBL] [Abstract][Full Text] [Related]
12. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
[TBL] [Abstract][Full Text] [Related]
13. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
[TBL] [Abstract][Full Text] [Related]
14. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
15. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison.
Awan MJ; Mohamed AS; Lewin JS; Baron CA; Gunn GB; Rosenthal DI; Holsinger FC; Schwartz DL; Fuller CD; Hutcheson KA
Oral Oncol; 2014 Aug; 50(8):746-52. PubMed ID: 24906528
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
17. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
18. Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.
Kil WJ; Kulasekere C; Hatch C; Bugno J; Derrwaldt R
Head Neck; 2017 Aug; 39(8):E85-E91. PubMed ID: 28475284
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]